Wilmington, Delaware, United States, Transparency Market Research Inc. - Cancer profiling is an alternative to all traditional approaches to cancer treatment. It uses a focused personalized approach to a treatment that specifically targets an individual patient’s tumor.
Wilmington, Delaware, United States, Transparency Market Research Inc. - Cancer profiling is an alternative to all traditional approaches to cancer treatment. It uses a focused personalized approach to a treatment that specifically targets an individual patient’s tumor. Laboratory tests are carried to identify certain genes or gene mutations (changes), proteins, or other biomarkers in a sample of tumor tissue in order to provide a better, personalized treatment to the cancer patient.
Access Full Report @ https://www.transparencymarketresearch.com/cancer-profiling-market.html
Key Drivers and Restraints of Global Cancer Profiling Market
Rise in incidence rate of cancer worldwide is the major factor driving the market. Cancer is one of the leading causes of death, globally, after cardiovascular diseases. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths each year, with 70% new cancer cases expected to be reported over the next 20 years. Increase in cancer afflicted population is anticipated to be a key driver of the market. According to a Centers for Disease Control and Prevention (CDC) report in 2014, the number of cancer patients diagnosed in the U.S. reached approximately 21 million. This number is estimated to reach 25.4 million by the end of 2024. Rising cancer cases boost the demand for early diagnosis or profiling of cancer, which ultimately fuels the market.
Government funding for continuing research in tumor or cancer diagnostics and profiling is another major factor driving the market. Governments in developed and developing countries are conducting awareness campaigns to encourage people to opt for early diagnosis of cancer in order to reduce mortality and morbidity rate. This, in turn, is projected to boost the cancer profiling market during the forecast period. In April 2016, the U.S. Government assigned US$ 5.2 Bn for the National Cancer Institute (NCI). The budget was improved by 5.3% in comparison with the previous year. NCI conducts clinical trials on cancer patients who require repetitive diagnosis to check the prognosis of cancer.
Technical issues with sample collection and storage is a key factor that is anticipated to hamper the market. Stringent quality control of these samples is required, and they need to be stored under the right conditions in order to prevent loss.
Request Brochure of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=79924
Next Generation Sequencing Segment to Expand Significantly
Based on technology, the global cancer profiling market can be divided into: immunoassays, next generation sequencing, polymerase chain reaction, in situ hybridization, microarrays, mass spectrometry, and others
The immunoassays segment, which includes immunohistochemistry, dominated the global cancer profiling market in 2019, followed by the next generation sequencing segment. Immunoassay is a conventional test that can detect changes at the protein level that occur not only from gene aberrations, most commonly gene amplifications, but also from specific DNA rearrangements or point mutations.
The next generation sequencing segment is estimated to expand at a significant growth rate during the forecast period. Advances in sequencing technologies, such as whole genome sequencing, have facilitated the simultaneous detection of single nucleotide variants (SNV), copy number variations, and structural rearrangements, such as gene fusions, leading to greater diagnostic yield of actionable findings in tumor samples.
Breast Cancer Segment to Dominate Global Cancer Profiling Market
Based on cancer type, the global cancer profiling market can be segmented into: breast cancer, lung cancer, prostate cancer, melanoma, and others
The most commonly diagnosed cancers are prostate in males and breast in females, while lung cancer remains the most common cause of cancer death in both sexes. The breast cancer segment accounted for a major share of the global cancer profiling market, in terms of revenue, in 2019, followed by lung cancer. Rising prevalence of breast cancer across the globe is the major factor fueling the market. According to WHO, in 2018, 627,000 women were estimated to have died from breast cancer, i.e., approximately 15% of all cancer deaths among women.
On the other hand, the lung cancer segment is estimated to expand at a notable CAGR during the forecast period majorly due to an increase in incidence and need for early diagnosis
Request For Custom Research @ https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=79924
Protein Biomarker Witness Highest Growth
Based on biomarker type, the global cancer profiling market can be divided into: genetic biomarkers, protein biomarkers, and others
Biomarkers are molecules that indicate normal or abnormal process taking place in the body and may be a sign of an underlying condition or disease. The genetic biomarkers segment held a significant share of the global cancer profiling market in 2019. Tumor-specific genetic changes, such as promoter methylation, gene mutations, or circulating small RNAs, are easily detected by genetic biomarkers.
However, protein biomarkers hold a strong opportunity to be converted into clinical diagnostic tests. Protein-based immunoassay is a quite rapid and efficient process. Novel proteomic biomarker discovery technologies are being developed using quantitative isotopic labeling, improved mass spectroscopy algorithms, and addressing the problems of sample preparation.
Research Application is estimated to dominate the Global Cancer Profiling Market
Based on application, the global cancer profiling market can be divided into research application and clinical application
In terms of revenue, the research application segment accounted for a major share of the market in 2019. Various novel molecular characterization strategies beyond tumor DNA sequencing, such as transcriptomics, immunophenotyping, epigenetic profiling, and single-cell analyses are presently being utilized in cancer or tumor profiling process. Extensive research in technological developments has made a molecular profiling analysis possible, which enables doctors to distinguish molecular differences between cancer cells and healthy cells. Additionally, rise in funding for cancer research is further propelling the market.
Ask References @ https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=79924
North America to Dominate Global Cancer Profiling Market
In terms of region, the global cancer profiling market can be divided into: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
In terms of revenue, North America dominated the cancer profiling market. Increase in incidence of cancer diseases, rising investment in research & development of cancer diagnostics, and continuous mergers & acquisitions between companies contribute to the leading share held by the region. Cancer is a leading cause of death in Canada, and the second-leading cause, after heart disease, in the U.S. According to American Cancer Society approximately 1.9 million new cancer cases and 693,000 cancer deaths were estimated to have occurred in North America in 2018.
The market in Asia Pacific is projected to expand at a notable CAGR during the forecast period. Focus of local players on enhancing their presence in rural areas of emerging regions of the market, such as India, is increasing. Moreover, demand for efficient diagnosis for various cancers is high. These factors are expected to drive the cancer profiling market in Asia Pacific during the forecast period.
Make an Enquiry before Buying @ https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=79924
Key Manufacturers Operating in Market
The global cancer profiling market was highly fragmented in 2019. Key manufacturers operating in the global market are:
- Illumina, Inc.
- Qiagen N.V.
- Neogenomics Laboratories Inc.
- HTG Molecular Diagnostics, Inc.
- Genomic Health Inc.
- Caris Life Sciences
- Helomics Corporation
- NanostringTechologies
- Oxford Gene Technology
- Ribomed Biotechnologies, Inc.
- GenomeDX
- Guardant Health
- Foundation Medicine
More Related Reports by Transparency Market Research –
Electronic Health Records Market: According to the report, the global electronic health records market was valued at US$ 26,126.3 Mn in 2018 and is anticipated to expand at a CAGR of 4.8% from 2019 to 2027.
Hospital Asset Management Market: According to the report, the global hospital asset management market was valued at US$ 5,986.5 Mn in 2018 and is anticipated to expand at a CAGR of 9.5% from 2019 to 2027
Blood Purification Equipment Market: The global blood purification equipment market was worth US$ 10.3 Bn and is projected to reach a value of US$ 22.9 Bn by the end of 2030
eHealth Market: The eHealth market is expected to reach a value of ~US$ 693 Bn by the end of 2030.
Video Telemedicine Market: Video telemedicine market was valued at US$ 1.2 Bn in 2019 and expected to reach US$ 4 Bn by 2030 end
Smart Healthcare Products Market: According to the report, the global smart healthcare products market was valued at US$ 37.5 Bn in 2018 and is anticipated to expand at a CAGR of 8.8% from 2019 to 2027
Plasma Feed Market: The global plasma feed market was worth US$ 2.4 Bn and is projected to reach a value of US$ 4.1 Bn by the end of 2030
Learning Disabilities Treatment Market: The learning disabilities treatment market is poised to reach a value of ~US$ 6 Bn by the end of 2027.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com